Cargando…
Techniques for the Assessment of In Vitro and In Vivo Antifungal Combinations
Systemic fungal infections are associated with high mortality rates despite adequate treatment. Moreover, acquired resistance to antifungals is increasing, which further complicates the therapeutic management. One strategy to overcome antifungal resistance is to use antifungal combinations. In vitro...
Autores principales: | Bidaud, Anne-Laure, Schwarz, Patrick, Herbreteau, Guillaume, Dannaoui, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913650/ https://www.ncbi.nlm.nih.gov/pubmed/33557026 http://dx.doi.org/10.3390/jof7020113 |
Ejemplares similares
-
In vitro synergy of isavuconazole in combination with colistin against Candida auris
por: Schwarz, Patrick, et al.
Publicado: (2020) -
In vitro and in vivo evaluation of antifungal combinations against azole-resistant Aspergillus fumigatus isolates
por: Jemel, Sana, et al.
Publicado: (2023) -
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
por: Schwarz, Patrick, et al.
Publicado: (2022) -
In Vitro Activity of Amphotericin B in Combination with Colistin against Fungi Responsible for Invasive Infections
por: Schwarz, Patrick, et al.
Publicado: (2022) -
In Vitro Interaction between Isavuconazole and Tacrolimus, Cyclosporin A, or Sirolimus against Aspergillus Species
por: Schwarz, Patrick, et al.
Publicado: (2020)